Prevention of pancreatic cancer

被引:2
|
作者
Scheruebl, Hans [1 ]
机构
[1] Vivantes Klinikum Am Urban, Klin Gastroenterol Gastrointestinale Onkol & Infe, D-10967 Berlin, Germany
关键词
screening; pancreas; cancer; risk factors; HIGH-RISK INDIVIDUALS;
D O I
10.1055/a-1975-2366
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of pancreatic cancer is rising in Germany. At present pancreatic cancer is the third commonest cause of cancer death but is expected to become the second in 2030 and finally the leading cause of cancer death in 2050. Pancreatic ductal adenocarcinoma (PC) is generally diagnosed at far advanced stages and 5-year-survival has remained poor. Modifiable risk factors of PC are tobacco smoking, excess body weight, alcohol use, type 2-diabetes and the metabolic syndrome. Smoking cessation and -in case of obesity- intentional weight loss can reduce PC risk by as much as 50 %. Early detection of asymptomatic sporadic PC at stage IA - stage IA-PC now has a 5-year-survival rate of about 80 %- has become a realistic chance for people older than 50 years with new-onset diabetes.
引用
收藏
页码:246 / 252
页数:7
相关论文
共 50 条
  • [41] Secondary prevention of pancreatic cancer in high-risk individuals
    Bleiker, Eveline M. A.
    PSYCHO-ONCOLOGY, 2018, 27 : 30 - 30
  • [42] Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean Cancer Prevention Study
    de Gonzalez, Amy Berrington
    Yun, Ji Eun
    Lee, Sang-Yi
    Klein, Alison P.
    Jee, Sun Ha
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (02) : 359 - 364
  • [43] Phytochemicals for the prevention and treatment of pancreatic cancer: Current progress and future prospects
    Casarcia, Nicolette
    Rogers, Patrick
    Guld, Emma
    Iyer, Samvit
    Li, Yutong
    Burcher, Jack T.
    Deliberto, Lindsay K.
    Banerjee, Sabyasachi
    Bishayee, Anupam
    BRITISH JOURNAL OF PHARMACOLOGY, 2023,
  • [44] AGFD 243-Potential of citrus limonoids in pancreatic cancer prevention
    Murthy, Kotamballi N. Chidambara
    Jayaprakasha, G. K.
    Safe, Stephen H.
    Patil, Bhimanagouda S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [45] JMJD1a: A potential target for prevention and therapy in pancreatic cancer
    Palaniyandi, Kanagaraj
    Paul, Santanu
    Rangarajan, Parthasarathy
    Kwatra, Deep
    Ramalingam, Satish
    Subramaniam, Dharmalingam
    Iwakuma, Tomoo
    Padhye, Subhash
    Anant, Shrikant
    Dhar, Animesh
    CANCER RESEARCH, 2014, 74 (19)
  • [46] Obesity and Pancreatic Cancer Overview of Epidemiology and Potential Prevention by Weight Loss
    Xu, Mu
    Jung, Xiaoman
    Hines, O. Joe
    Eibl, Guido
    Chen, Yijun
    PANCREAS, 2018, 47 (02) : 158 - 162
  • [47] Pancreatic Cancer in Israel: The Epidemiology, Possibilities of Prevention, Early Detection and Screening
    Rozen, Paul
    Liphshitz, Irena
    Rosner, Guy
    Barchana, Micha
    Lachter, Jesse
    Pel, Sara
    Shohat, Tami
    Santo, Erwin
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (12): : 710 - 713
  • [48] Pancreatic cancer in hereditary pancreatitis: Consensus guidelines for prevention, screening and treatment
    Ulrich, CD
    PANCREATOLOGY, 2001, 1 (05) : 416 - 422
  • [49] Rac1 is a therapeutic target for pancreatic cancer prevention and treatment
    Lubeseder-Martellato, C.
    Heid, I.
    Sipos, B.
    Rieder, S.
    Schmid, R. M.
    Siveke, J. T.
    EJC SUPPLEMENTS, 2010, 8 (07): : 86 - 86
  • [50] The role of vitamin C in the prevention of pancreatic cancer: a systematic-review
    Martinez-Dominguez, Samuel J.
    Laredo, Viviana
    Garcia-Rayado, Guillermo
    FRONTIERS IN NUTRITION, 2024, 11